1. Home
  2. CGEM vs ILPT Comparison

CGEM vs ILPT Comparison

Compare CGEM & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ILPT
  • Stock Information
  • Founded
  • CGEM 2016
  • ILPT 2017
  • Country
  • CGEM United States
  • ILPT United States
  • Employees
  • CGEM N/A
  • ILPT N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ILPT Real Estate Investment Trusts
  • Sector
  • CGEM Health Care
  • ILPT Real Estate
  • Exchange
  • CGEM Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • CGEM 437.2M
  • ILPT 366.2M
  • IPO Year
  • CGEM 2021
  • ILPT 2018
  • Fundamental
  • Price
  • CGEM $8.49
  • ILPT $5.80
  • Analyst Decision
  • CGEM Strong Buy
  • ILPT
  • Analyst Count
  • CGEM 7
  • ILPT 0
  • Target Price
  • CGEM $26.00
  • ILPT N/A
  • AVG Volume (30 Days)
  • CGEM 1.5M
  • ILPT 245.4K
  • Earning Date
  • CGEM 11-07-2025
  • ILPT 10-28-2025
  • Dividend Yield
  • CGEM N/A
  • ILPT 3.45%
  • EPS Growth
  • CGEM N/A
  • ILPT N/A
  • EPS
  • CGEM N/A
  • ILPT N/A
  • Revenue
  • CGEM N/A
  • ILPT $443,468,000.00
  • Revenue This Year
  • CGEM N/A
  • ILPT $3.44
  • Revenue Next Year
  • CGEM N/A
  • ILPT $1.78
  • P/E Ratio
  • CGEM N/A
  • ILPT N/A
  • Revenue Growth
  • CGEM N/A
  • ILPT 0.36
  • 52 Week Low
  • CGEM $5.68
  • ILPT $2.45
  • 52 Week High
  • CGEM $17.50
  • ILPT $6.57
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 62.54
  • ILPT 52.27
  • Support Level
  • CGEM $7.69
  • ILPT $5.42
  • Resistance Level
  • CGEM $8.69
  • ILPT $6.08
  • Average True Range (ATR)
  • CGEM 0.65
  • ILPT 0.19
  • MACD
  • CGEM 0.06
  • ILPT 0.06
  • Stochastic Oscillator
  • CGEM 72.76
  • ILPT 72.28

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: